Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.9K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

6.9K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.9K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

1.0K
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

893
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The Association of Race and Ethnicity with Six-Minute Walk Distance: The Multi-Ethnic Study of Atherosclerosis.

Ethnicity & disease·2026
Same author

Identification of Frailty Subtypes in African American Adults With and Without Type 2 Diabetes: A Latent Class Analysis From the Jackson Heart Study.

Diabetes, obesity & metabolism·2026
Same author

Improving Health Equity for Spanish-Speaking Latine Communities: Community Priorities, Challenges, and Recommendations.

International journal of environmental research and public health·2026
Same author

Associations of noninvasive measures of adiposity with aortic stiffness and microvascular function: The Jackson Heart Study.

American journal of preventive cardiology·2026
Same author

Psychosocial Risk and Resilience as Moderators of the Association Between Neighborhood Disadvantage and Incident Cardiovascular Disease Across Ethnoracial Groups: Multi-Ethnic Study of Atherosclerosis, United States, 2000-2019.

American journal of public health·2026
Same author

Physical rehabilitation for older patients with acute HFpEF (REHAB-HFpEF) trial: Design and rationale.

American heart journal·2026

Video Experimental Relacionado

Updated: May 6, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

10.5K

La salud cardiovascular en los afroamericanos: una declaración científica de la Asociación Americana del Corazón

Mercedes R Carnethon, Jia Pu, George Howard

    Circulation
    |October 25, 2017
    PubMed
    Resumen

    Las enfermedades cardiovasculares afectan desproporcionadamente a los afroamericanos debido a los factores de riesgo más altos y al manejo menos efectivo, lo que lleva a importantes disparidades de salud. Abordarlos requiere un enfoque multidisciplinario para promover la equidad en la salud cardiovascular.

    Palabras clave:
    Declaraciones científicas de la AHALos afroamericanosEnfermedades cardiovascularesgestión de enfermedadesPrevención y controlFactores de riesgo

    Más Videos Relacionados

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
    08:15

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

    Published on: January 31, 2020

    9.2K
    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.6K

    Videos de Experimentos Relacionados

    Last Updated: May 6, 2026

    An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
    07:15

    An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

    Published on: July 31, 2019

    10.5K
    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
    08:15

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

    Published on: January 31, 2020

    9.2K
    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.6K

    Área de la Ciencia:

    • Salud pública
    • Cardiología
    • Disparidades en materia de salud

    Sus antecedentes:

    • Las reducciones en la incidencia y mortalidad de enfermedades cardiovasculares (ECV) no se comparten por igual entre los afroamericanos.
    • Las enfermedades cardiovasculares siguen siendo una causa principal de las disparidades en la esperanza de vida entre los afroamericanos y los blancos.
    • Los afroamericanos experimentan una carga desproporcionadamente alta de enfermedades cardiovasculares.

    Objetivo del estudio:

    • Para describir el estado actual de la salud cardiovascular en los afroamericanos.
    • Resaltar las consideraciones únicas para la prevención y el tratamiento de las ECV en esta población.
    • Para hacer frente a las desigualdades cardiovasculares persistentes.

    Principales métodos:

    • Revisión de la literatura utilizando PubMed y Medline.
    • Análisis de datos en línea de los Centros para el Control y la Prevención de Enfermedades.
    • Síntesis de información sobre las enfermedades cardiovasculares en los afroamericanos.

    Principales resultados:

    • Una mayor prevalencia de los factores de riesgo tradicionales de ECV (hipertensión, diabetes, obesidad) conduce a una aparición más temprana de ECV en los afroamericanos.
    • La hipertensión es muy frecuente, contribuyendo a las disparidades en los accidentes cerebrovasculares, la insuficiencia cardíaca y la enfermedad arterial periférica.
    • A pesar de los tratamientos efectivos, el manejo de la enfermedad es menos efectivo, lo que resulta en mayores tasas de mortalidad entre los afroamericanos.

    Conclusiones:

    • Las explicaciones multifactoriales de las disparidades de las enfermedades cardiovasculares abarcan desde los niveles individuales hasta los ambientales sociales.
    • La promoción de la equidad en la salud cardiovascular requiere una amplia participación de las partes interesadas.
    • Los médicos e investigadores de todas las disciplinas deben colaborar para abordar estas desigualdades.